Pink Sheet is part of Pharma Intelligence UK Limited

This site is operated by Pharma Intelligence UK Limited, a company registered in England and Wales with company number 13787459 whose registered office is 5 Howick Place, London SW1P 1WG. The Pharma Intelligence group is owned by Caerus Topco S.à r.l. and all copyright resides with the group.

This copy is for your personal, non-commercial use. For high-quality copies or electronic reprints for distribution to colleagues or customers, please call +44 (0) 20 3377 3183

Printed By

Brought to you by

Ixchelsis raises $14mm through Series A

Executive Summary

Ixchelsis Ltd. (male sexual health therapeutics) has raised over $14mm in its Series A venture round. TVM Capital, through its TVM Life Sciences Ventures VII fund, was the sole investor and one of the VC’s directors will take a seat on the company’s board. The money will be distributed in several tranches.
Deal Industry
  • Biotechnology
  • Pharmaceuticals
Deal Status
  • Final
Deal Type
  • Financing
    • Venture Financing

Related Companies